scispace - formally typeset
S

Simon E. Ward

Researcher at Discovery Institute

Publications -  102
Citations -  1950

Simon E. Ward is an academic researcher from Discovery Institute. The author has contributed to research in topics: AMPA receptor & Receptor. The author has an hindex of 22, co-authored 100 publications receiving 1614 citations. Previous affiliations of Simon E. Ward include University of Cambridge & Discovery Centre.

Papers
More filters
Journal ArticleDOI

Therapeutic opportunities within the DNA damage response

TL;DR: An in-depth analysis of the function, role and therapeutic potential of 450 expert-curated human DDR genes is presented, and systematic computational analysis is applied to identify DDR proteins that are amenable to modulation by small molecules, highlighting potential novel therapeutic targets.
Journal ArticleDOI

Synthesis of polyprenylated acylphloroglucinols using bridgehead lithiation: the total synthesis of racemic clusianone and a formal synthesis of racemic garsubellin A.

TL;DR: The synthesis of polyprenylated phloroglucinol natural products, including clusianone, nemorosone, and garsubellin A, was pursued by a strategy involving construction of a core bicyclo nonanetrione structure and subsequent elaboration via organolithium intermediates.
Journal ArticleDOI

Challenges for and current status of research into positive modulators of AMPA receptors

TL;DR: The challenges involved in identifying a chemically distinct series of AMPA receptor positive modulators are outlined, addressing the challenges created by the heterogeneity of the AMPA receptors populations and the development of structure‐activity relationships driven by homomeric, recombinant systems on high‐throughput platforms are addressed.
Journal ArticleDOI

A proposed new definition and measurement of the shielding effect of equipment enclosures

TL;DR: In this article, the authors describe the rationale behind a new proposed measurement of the screening effect of an equipment enclosure that takes into account the contents of the enclosure, using a set of representative contents for enclosures.
Journal ArticleDOI

Clinical and Cellular Roles for TDP1 and TOP1 in Modulating Colorectal Cancer Response to Irinotecan

TL;DR: TDP1 is established as a potential therapeutic target for the treatment of colorectal cancer and the validity of TOP1 or TDP1 on their own as predictive biomarkers for irinotecan response is questioned.